Your browser doesn't support javascript.
loading
Efficacy and Safety of Abicipar in Neovascular Age-Related Macular Degeneration: 52-Week Results of Phase 3 Randomized Controlled Study.
Kunimoto, Derek; Yoon, Young Hee; Wykoff, Charles C; Chang, Andrew; Khurana, Rahul N; Maturi, Raj K; Agostini, Hansjürgen; Souied, Eric; Chow, David R; Lotery, Andrew J; Ohji, Masahito; Bandello, Francesco; Belfort, Rubens; Li, Xiao-Yan; Jiao, Jenny; Le, Grace; Schmidt, Werner; Hashad, Yehia.
Afiliación
  • Kunimoto D; Retinal Consultants of Arizona, Phoenix, Arizona. Electronic address: derek_kunimoto@yahoo.com.
  • Yoon YH; Asan Medical Center, University of Ulsan, Seoul, South Korea.
  • Wykoff CC; Retina Consultants of Houston, Houston, Texas.
  • Chang A; Sydney Retina Clinic, Sydney, Australia; Save Sight Institute, University of Sydney, Sydney, Australia.
  • Khurana RN; Northern California Retina Vitreous Associates, Mountain View, California.
  • Maturi RK; Midwest Eye Institute, Indianapolis, Indiana; Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana.
  • Agostini H; Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Souied E; Centre Hospitalier Creteil, Service Universitaire d'Ophthalmologie, Creteil, France.
  • Chow DR; St. Michael's Hospital, University of Toronto, Ontario, Canada; Toronto Retina Institute, North York, Ontario, Canada.
  • Lotery AJ; University of Southampton, Southampton, United Kingdom.
  • Ohji M; Department of Ophthalmology, Shiga University of Medical Science, Shiga, Japan.
  • Bandello F; University Vita-Salute Scientific Institute, Hospital San Raffaele, Milan, Italy.
  • Belfort R; Vision Institute, Federal University of São Paulo, São Paulo, Brazil.
  • Li XY; Allergan plc, Irvine, California.
  • Jiao J; Allergan plc, Irvine, California.
  • Le G; Allergan plc, Irvine, California.
  • Schmidt W; Allergan plc, Irvine, California.
  • Hashad Y; Allergan plc, Irvine, California.
Ophthalmology ; 127(10): 1331-1344, 2020 10.
Article en En | MEDLINE | ID: mdl-32471729
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Recombinantes de Fusión / Agudeza Visual / Degeneración Macular Húmeda / Mácula Lútea Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Ophthalmology Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Recombinantes de Fusión / Agudeza Visual / Degeneración Macular Húmeda / Mácula Lútea Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Ophthalmology Año: 2020 Tipo del documento: Article